Skip to main content
. 2011 Feb 12;10:3. doi: 10.4103/1477-3163.76723

Figure 1.

Figure 1

Plasma concentrations of FGF-23 by 1,25(OH)2D (panel a) and 25(OH)D (panel b) concentrations. Analyses were conducted using linear regression modeling with vitamin D metabolites as the continuous outcome variable and FGF-23 as the continuous exposure variable.